Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23


The abstract submission is now closed!

Accepted abstracts are available online

Abstract submission deadline


Date and Time


6 January 2021, 21:00 CET (Central European Time) 

Outcome notifications

Outcome notifications are expected to be made available to first authors by mid-January 2021.

Abstract submission categories

  • Immunotherapy
  • Kinase-targeting agents
  • Antibody-based therapies
  • Epigenetics
  • DNA damage repair
  • Cell therapy
  • Miscellaneous

Presentation and publication of abstracts accepted for TAT 2021

The TAT 2021 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:

  • Proffered Paper (oral presentation) – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
  • Mini Oral – Short presentation by authors with comment and interactive audience discussion led by an invited expert.
  • Poster – An important method for communicating details of scientific research, posters will be on display for the duration of the Congress.

All accepted abstracts will be published as a supplement to the official ESMO journal, Annals of Oncology.

Publication schedule for accepted abstracts:

Abstracts accepted for presentation at TAT 2021 as Proffered Paper (oral presentation), Mini Oral and Poster will be published online on the ESMO website at 08:00 CET on Monday, 1 March 2021.


Date and Time

Abstracts accepted as:

  • Proffered Paper (suffix ‘O’)
  • Mini Oral (suffix ‘MO’)
  • Poster (suffix ‘P’)

Monday, 1 March 2021
08:00 Central European Time (CET) (local Swiss time)

Registration Grants 

A restricted number of registration grants to TAT 2021 are available, upon application, to first author (= presenter) of candidates under the age of 40 who submit abstracts considered deserving of recognition. Selection will be made by the TAT 2021 Scientific Committee on a competitive basis from among the accepted abstracts.​

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.